Main characteristics of the subjects considered in the study
| . | No. of subjects . | Age, y . | Duration of disease, y . | Body mass index, kg/m2 . | Fasting blood glucose, mM/L . | HbA1c, % . | Fructosamine, μM/100 mL . |
|---|---|---|---|---|---|---|---|
| Controls | 95 | 49 ± 13 | 26.12 ± 0.05 | 5.0 ± 0.6 | 4.5 ± 0.9 | 215 ± 30 | |
| Total diabetic patients | 117 | 63 ± 9 | 11.7 ± 8.2 | 30.8 ± 5.6 | 9.9 ± 3.3 | 7.6 ± 1.5 | 340 ± 60 |
| Diabetics with complications | 60 | 63 ± 7 | 14.1 ± 7.6 | 31.1 ± 5.4 | 10.9 ± 3.7 | 7.9 ± 1.6 | 345 ± 65 |
| Diabetics without complications | 57 | 62 ± 8 | 9.8 ± 6.8 | 30.2 ± 6.0 | 8.7 ± 1.3 | 7.1 ± 1.1 | 325 ± 55 |
| Untreated diabetics | 14 | 62 ± 7 | 5.2 ± 4.1 | 28.8 ± 4.0 | 7.8 ± 1.1 | 6.0 ± 0.4 | 274 ± 29 |
| Diabetics treated with oral hypoglycemic agents only | 68 | 62 ± 8 | 10.8 ± 7.5 | 31.3 ± 6.2 | 9.7 ± 2.9 | 7.2 ± 1.6 | 329 ± 44 |
| Diabetics treated with oral hypoglycemic agents and insulin | 35 | 64 ± 6 | 17.3 ± 7.1 | 29.7 ± 3.9 | 10.8 ± 3.9 | 8.4 ± 1.4 | 389 ± 83 |
| . | No. of subjects . | Age, y . | Duration of disease, y . | Body mass index, kg/m2 . | Fasting blood glucose, mM/L . | HbA1c, % . | Fructosamine, μM/100 mL . |
|---|---|---|---|---|---|---|---|
| Controls | 95 | 49 ± 13 | 26.12 ± 0.05 | 5.0 ± 0.6 | 4.5 ± 0.9 | 215 ± 30 | |
| Total diabetic patients | 117 | 63 ± 9 | 11.7 ± 8.2 | 30.8 ± 5.6 | 9.9 ± 3.3 | 7.6 ± 1.5 | 340 ± 60 |
| Diabetics with complications | 60 | 63 ± 7 | 14.1 ± 7.6 | 31.1 ± 5.4 | 10.9 ± 3.7 | 7.9 ± 1.6 | 345 ± 65 |
| Diabetics without complications | 57 | 62 ± 8 | 9.8 ± 6.8 | 30.2 ± 6.0 | 8.7 ± 1.3 | 7.1 ± 1.1 | 325 ± 55 |
| Untreated diabetics | 14 | 62 ± 7 | 5.2 ± 4.1 | 28.8 ± 4.0 | 7.8 ± 1.1 | 6.0 ± 0.4 | 274 ± 29 |
| Diabetics treated with oral hypoglycemic agents only | 68 | 62 ± 8 | 10.8 ± 7.5 | 31.3 ± 6.2 | 9.7 ± 2.9 | 7.2 ± 1.6 | 329 ± 44 |
| Diabetics treated with oral hypoglycemic agents and insulin | 35 | 64 ± 6 | 17.3 ± 7.1 | 29.7 ± 3.9 | 10.8 ± 3.9 | 8.4 ± 1.4 | 389 ± 83 |
Values are expressed as mean ± SD.
HbA1c reference interval: 4.0% to 5.8%; fructosamine reference interval: 100 to 278 μM/100 mL.